Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8229651 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 8 Pages |
Abstract
Proton therapy to ablative doses is well tolerated and produces promising local control rates for medically inoperable early-stage NSCLC.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Joe Y. M.D., Ph.D., Ritsuko M.D., Hong Y. M.S., Beth B.S., B.A., Jaques B. M.S., Mary F. M.D., Ph.D., Stephen G. M.D., Michael Ph.D., Radhe Ph.D., James D. M.D.,